Drug Coverage
Drug Coverage
Navigating Drug Formularies
Schaeffer experts evaluate trends in drug formularies and utilization restrictions to determine whether patients are getting access to high-value medicines.
Related Topics
Top Drug Coverage Stories View All
News
White House Move to Expand Obesity Drug Access Informed by Schaeffer Research
In The News View All
Tradeoffs
Trish interviewed on rising Medicare drug plan costs and narrowing options
Featured Experts: Erin Trish
CNBC
Lakdawalla discusses how White House obesity deal will broaden access
Featured Experts: Darius Lakdawalla
Tradeoffs Podcast
Lakdawalla interviewed about the uncertain impacts of the White House’s recent drug pricing deals
Featured Experts: Darius Lakdawalla
The New York Times
Employers face a growing challenge in managing the costs of specialty drugs, Ginsburg says
Featured Experts: Paul Ginsburg
MarketWatch
Joyce explains why patients’ drug costs may vary from pharmacy to pharmacy
Featured Experts: Geoffrey Joyce
Featured Perspective
A Missed Chance to Make America Healthier and Richer
Medicare should revisit its decision not to broadly cover anti-obesity medications, considering the enormous value expanded access would generate for society.
Experts: Alison Sexton Ward, Dana Goldman
Drug Coverage
Experts
Featured Research
Medicare Part D Plans Increased Restrictions on Drug Coverage
Medicare Part D plans excluded more compounds from coverage or subjected more of them to review before patients can access treatments, USC researchers found.
Experts: Geoffrey Joyce, Karen Van Nuys
